Olga Goloubeva
Overview
Explore the profile of Olga Goloubeva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
2849
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen D, Goloubeva O, Rapoport A, Dahiya S, Atanackovic D, Hardy N, et al.
Clin Lymphoma Myeloma Leuk
. 2025 Jan;
PMID: 39865000
Background: Anti-CD19 CAR-T therapy has been a breakthrough in treatment of primary refractory or relapsed large B-cell lymphoma (r/r LBCL) and is poised to supplant previous second line of high...
2.
Derakhshandeh R, Zhu Y, Li J, Hester D, Younis R, Koka R, et al.
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596374
Cancer immunotherapy has emerged as an effective, personalized treatment for certain patients, particularly for those with hematological malignancies. However, its efficacy in breast cancer has been marginal-perhaps due to cold,...
3.
Sanchez-Petitto G, Goloubeva O, Childress J, Iqbal T, Masur J, An M, et al.
Acta Haematol
. 2024 Aug;
:1-12.
PMID: 39191224
Introduction/background: Reduced-intensity conditioning (RIC) and nonmyeloablative (NMA) regimens have enabled patients with cardiovascular disease (CVD) to undergo allogeneic stem cell transplantation (allo-HSCT). However, little is known about long-term outcomes, including...
4.
Lutfi F, Goloubeva O, Kowatli A, Gryaznov A, Kim D, Dureja R, et al.
Clin Lymphoma Myeloma Leuk
. 2023 Jul;
23(10):757-763.
PMID: 37453865
CD19 directed CAR-T therapy for Large B-cell lymphoma (LBCL) has shown great therapeutic response in patients with relapsed/refractory disease with response rates of 60-80%. However, in patients with a partial...
5.
Alkhaldi H, Goloubeva O, Rapoport A, Dahiya S, Pang Y, Mustafa Ali M, et al.
Transplant Proc
. 2023 Jan;
55(1):214-224.
PMID: 36635141
Background: Reduced intensity conditioning (RIC) regimens decrease the risk for nonrelapse mortality (NRM) in adult patients undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies but increase the risk for...
6.
Amin N, Thompson J, Goloubeva O, Witek M, Taylor R, Wolf J, et al.
ORL J Otorhinolaryngol Relat Spec
. 2022 Sep;
84(6):438-446.
PMID: 36067748
Introduction: The study objective was to identify practice patterns in oropharyngeal cancer management from 2010 to 2016 among human papillomavirus (HPV)-associated and non-HPV-associated oropharyngeal squamous-cell carcinoma (OPSCC) patients. Methods: The...
7.
Albarmawi H, Cullen K, Mehra R, Onukwugha E, Goloubeva O
J Comp Eff Res
. 2022 May;
11(8):595-607.
PMID: 35543585
To assess the cost-effectiveness of definitive therapies for nonmetastatic oropharyngeal cancer (OPC). Using the Surveillance, Epidemiology and End Results-Medicare dataset, patients diagnosed between 2000 and 2011 were identified. The cost-effectiveness...
8.
Saharia K, Husson J, Niederhaus S, Iraguha T, Avila S, Yoo Y, et al.
Clin Transl Immunology
. 2022 May;
11(5):e1391.
PMID: 35505864
Objectives: Solid organ transplant recipients (SOTR) receiving post-transplant immunosuppression show increased COVID-19-related mortality. It is unclear whether an additional dose of COVID-19 vaccines can overcome the reduced immune responsiveness against...
9.
Burrowes S, Goloubeva O, Keaser M, Haythornthwaite J, Seminowicz D
J Headache Pain
. 2021 Oct;
22(1):127.
PMID: 34688253
Background: Migraine sufferers face difficulties getting appropriate care and treatment. Migraine is associated with reduced gray matter volume (GMV) in several brain regions, which could be related to various clinical...
10.
Amr S, Ioffe D, Suzuki I, Mehra R, Cullen K, Goloubeva O
Head Neck
. 2021 Oct;
43(12):3935-3945.
PMID: 34632677
Background: Chemoradiation with curative intent in older adults with locally advanced head and neck squamous cell carcinoma (HNSCC) has been a challenge, because of its potential toxicities. Methods: We selected...